Yes, the truth just like filtered blue dye is better than unfiltered blue dye. Even though studies show otherwise. In filtered blue dye, the particles are too small to be retained in the localized area and are "flushed" from the desired location.
You also stated that the Lymphoseek studies were flawed in that they were compared to unfiltered blue dye rather than filter blue dye, which is supposedly better. That was totally incorrect, misleading, and an unfair statement. It calls into question every statement of "fact" you have made out here. Show a technical reference that states filtered blue dye is better than unfiltered...I have not seen a source reference stating as such. It validates the common consensus out here regarding your posts as being bogus and unfounded.
Thanks for the reply. I just don't get it. I pulled out any links, and I sited information from a technical paper that captured filtered verse unfiltered blue dye. It was based on an actual study. Bottom line is that filtered blue dye is not thought to be better than unfiltered blue dye, and any claims without supporting studies validates what is thought of some of the bashers out here who state they supposedly have nothing invested in the stock, either long or short.
I keep posting information countering the idea that filtered blue dye is better than unfiltered blue dye. The study suggests that unfiltered blue dye is actually better. The statement was made out here that Lymphoseek studies were somehow flawed because the comparator was unfiltered blue dye.
For some reason the post keeps getting deleted. WTH
Okay, is the process difference between filtered and unfiltered blue dye simply the presence of a filter? What is the porosity of the filter? Okay, so the difference cant be that simple. What is the difference between the two manufacturing processes? If it is "just" a filter, why would that make a difference and how does it improve the performance of blue dye?
I have not read every release and comparison study, but in all the years following this, I never recall hearing about filtered verses unfiltered blue dye.
Indeed...right there along with the idea that it will hit 5 bucks a share. Feel free to short...I will even lend you my shares to do so I can get the rumored high interest rate for doing so.
I think it is great that when a US company, such as PFE, goes to buy an overseas company, such as AZN, that the overseas company will get involved to ensure technology and jobs are guaranteed to be secured as part of the deal. Here, SLXP can be bought and theoretically everything shut down and moved overseas without any intervention. Perhaps the state of NC or the feds got involved, but I do not recall hearing anything about it.
Well, I am glad the offer price is moving up...too bad it took a counter offer from another company to get it there, but what ever. Seems like all cash would be better than one that involves stock. Recall the PFE deal when they purchased WYE. IT was a mix of cash and stock, which resulted in a "floating" price based on the price of PFE at the time. It was a set dollar amount per share plus a factor of the PFE share price at closing. The PFE share price "coincidentally" went down leading up the closing, which resulted in a lower overall price for WYE. If they set a fixed price in total, then I would be a bit more okay with a mix of cash and shares. Time will tell.
Ah, yes that makes more sense. There will not be movement without a source of non-dilutive funds. It always seems like so much potential, but never fails to fail fizzling out. This will be the last chance for them to get it right.
You get a finger up!
She has sung and it is lights out. Soon I would expect this board to go bye bye, so good luck to everyone out there who stuck with this dawg on false promises, including your's truly! Seemed like a lot of promise.
Well, looks like it is all over now. Trouble with the SEC and seems like the doors are closed. The shares are essentially worthless and the "leadership team" bled all they could from what was left. Tax write off in 2015 will be nice.
We will know the answer to one question in a few short weeks...and that is if they pooched the dawg again with the regulatory submission. Will they go 0 for 2 or get it in?? Can they adhere to one commitment?
Since the approval process can take approximately a year for approval (in most cases), I am not thinking any company would hold off since they do not have the money. Not sure what you meant that it would "fall on deaf ears" as the review process is not associated with the company financials. If they miss the submission date once again, it will be of their own doing and nobody else's since they supposedly had everything in place to do so. If they do miss it again, I am not sure how they are allowed to keep their jobs.
Indeed...not surprising. As much as it would suck, I can see them saying on the last day of the quarter that there were delays and they have to submit out into Q2. I can just hear it now....delay due to stability data or something not right with the CMC section. Oh wait, they have a contractor make it I believe so it will be their fault. I hear you on Ruane...I am sure he and his team never miss a free lunch or a bonus payout.
Honestly, I was being a bit facetious here. Okay, so a lot... I am not sure that getting the filing in will actually do anything. Nothing monetary tied to it, and it will be a year at the earliest before approval and six months after for them to launch. Any approval delay will be 3 to 6 months minimum. Not sure if there will be any interest in this company from any potential partners or buyers. If it has not happened now with the low share price and "all" of the great "news" communicated, then I am not confident it will be happening any time soon. This in turn reflects that the market potential of the indications they are going for are really not that big at all. There will be a reverse split followed by dilution. I see it going way of DNDN or GNTA. As always, I am fine being wrong if they would prove me to be.
Still has room to drop to get in line with the rest of the industry. This will happen one of two ways...either the share price will drop or the earnings will rise. Since they are predicting continued decline in revenue for two more years, then it will be due to a lower share price.
What is your basis for saying this? Do you really think they would offer 100 a share or higher? More than Pfizer? Could be, but if there were any talks going on, I would have expected to see AZN start ramping up again as it did when the PFE rumors started and then proven true. Nice try though...oh, and if it does prove to be true, I have no problems acknowledging your post as stating such.
Soon will be the moment we have waited for! The regulatory submission going in!! This will surely attract institutional investors, partners, and other interest...maybe a buyout??!! We have been in this long enough, so we deserve it!! 2 to 3 weeks and we are home free!
I am sure they can find one depending upon for how much they would sell out. On the reverse side, INSV has been around long enough and has had products/technology approved/commercialized, and they have communicated out that they are going to be submitting a regulatory submission in a few weeks. So my question is what is the business development functions at other companies not seeing that would draw some interest to potentially make a play for them? There again, no debt (well other than the recent 5 million increase), a submission going in over the next two or three weeks, great clinical data, and a really low market cap, but yet there is no noticeable interest.
Outside of the fact of this is their gravy train, why else would they let the value continue to erode and not find a buyer? Oh wait, what more reason do they need!
I always say that they have had the chance for years to prove me wrong, and I am more than happy with them doing so...but they never fail to fail in doing so. I would be the first to say I did not have a clue. Lol good luck to all of us!